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Abstract A highly water-soluble antihypertensive drug,
metoprolol tartrate (MT), was selected as a model drug for
preparation of multi-walled carbon nanotubes (MWCNTs)-
impregnated ethyl cellulose (EC) microspheres. The pres-
ent investigation was aimed to increase encapsulation
efficiency of MT with excellent adsorbent properties of
MWCNTs. The unique surface area, stiffness, strength and
resilience of MWCNTs have drawn much anticipation as
carrier for highly water-soluble drugs. Carbon nanotubes
drug adsorbate (MWCNTs:MT)-loaded EC microspheres
were further optimized by the central composite design of
the experiment. The effects of independent variables
(MWCNTs:MT and EC:adsorbate) were evaluated on
responses like entrapment efficiency (EE) and t50 (time
required for 50% drug release). The optimized batch was
compared with drug alone EC microspheres. The results
revealed high degree of improvement in encapsulation
efficiency for MWCNTs:MT-loaded EC microspheres.
In vitro drug release study exhibited complete release form
drug alone microspheres within 15 h, while by the same
time only 50–60% drug was released for MWCNTs-
impregnated EC microspheres. The optimized batch was
further characterized by various instrumental analyses such
as scanning electron microscopy, powder X-ray diffraction
and differential scanning calorimetry. The results endorse
encapsulation of MWCNTs:MT adsorbate inside the matrix
of EC microspheres, which might have resulted in
enhanced encapsulation and sustained effect of MT. Hence,
MWCNTs can be utilized as novel carriers for extended
drug release and enhanced encapsulation of highly water-
soluble drug, MT.
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Introduction
High water solubility of the active pharmaceuticals neces-
sitates a controlled and sustained release medication
(Choudhury and Kar 2009). There are several drug delivery
systems available to sustain the release rate of highly water-
soluble drugs. Among them, microencapsulation technique
has been a prime choice by most researchers (Yang et al.
2001; Luzzi and Palmier 1984). Microencapsulation being a
multi-unit particulate system bypasses the variations asso-
ciated with gastric emptying and different transit time
(Ghebre-Sellassie 1994). The uniform distribution of mul-
tiparticulate system along the gastrointestinal tract (GIT)
could lead to more reproducible drug absorption and min-
imize risk of local irritation as compared to single unit
dosage form (Galeone et al. 1981). Numerous methods have
been used to prepare polymeric microparticulate drug
delivery systems of highly water-soluble drugs (Benita et al.
1984; Bodmeier and McGinity 1987a, b; Jeffery et al. 1993;
Amperiadou and Georgarakis 1995a, b; Genta et al. 1997;
Schlicher et al. 1997; Ghorab et al. 1990; Cheu et al. 2001).
Different polymeric materials have been enveloped to
formulate microparticulate systems (microspheres),
which include chitosan, gelation, alginate, ethyl cellulose,
D-L-lactide-co-glycolide and their copolymers (Jeyanthi and
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Panduranga Rao 1988; Hazrati and DeLuca 1989) Ethyl
cellulose being a biocompatible and water-insoluble poly-
mer is one of the extensively studied encapsulating mate-
rials for sustained release (Benita and Donbrow 1982;
Amperiadou and Georgarakis 1995a, b; Yang et al. 2000;
Wade and Weller 1994; Chowdary et al. 2004). This is
attributed to its high safety, stability, easy fabrication and
low cost. Acetone was selected as a solvent for emulsifi-
cation processes based on human safety concern over the
disadvantageous impact of residue solvent (Sah 1997;
Allemann et al. 1993). Unfortunately, the number of
shortcomings associated with this carrier includes high drug
leakage, low mechanical strength and serious swelling due
to their open structure and large pore size (Choi and Han
2005; Ito et al. 2008; O’Donnell and McGinity 1997;
Blandino et al. 2000; Blandino et al. 2001; Bajpai and
Saxena 2004; Boonsongrit et al. 2008). These drawbacks
restrict the use of EC as a polymer for microencapsulation.
Various attempts have been done to overcome the problems
associated with EC, which includes cross linking (Anal and
Stevens 2006), solvent evaporation (Yang et al. 2005), ion
exchange (Abdekhodaie and Wu 2008) and surface coating
(Zhang et al. 2008), but to date none of them have shown
distinguished effectiveness.
Nanotechnology offers lots of openings and benefits for
new drug molecules with extensively enhanced character-
istics. Pharmaceutical innovations have chiefly concen-
trated on the design of modified release drug delivery
systems using diverse newly discovered excipients. In the
last few years, several carriers have been developed for
effective drug delivery of highly water-soluble drugs.
Carbon nanotubes (CNTs), being one of such carriers,
represent allotropes of carbon with cylindrical tubules-
shaped concentric graphitic (a hexagonal lattice of carbon)
sheets and capped by fullerene-like hemispheres with a
length to diameter ratio [1,000,000 (Iijima 1991). Their
inert nature (Bonard et al. 1998; Niyogi et al. 2002), large
surface area (Wu and Liao 2007), strong hydrophobic
property (Tagmatarchis and Prato 2005) and available
flexibility for physiochemical manipulation (Tasis et al.
2006) have sparked much interest in the pharmaceutical
scientist. Wide amount of research is dedicated to their
innovative applications in the design of the modified
release dosage form. CNTs are mechanically stable sub-
stances with special ability to incorporate material into
their inner hollow spaces (Ajima et al. 2005) or adsorption
over the surface (Davydov et al. 2005). CNTs-doped
microspheres of nicotinamide adenine dinucleotide with
increased loading efficiency were developed by Lu et al.
(2005). Jiang et al. (2006) have also developed micro-
spheres containing bovine serum albumin (BSA) using
CNTs as a carrier to overcome the drawbacks of polymeric
microspheres. They observed considerable reduction of
BSA leakage with dramatic increase in the strength of
microspheres. In light of these, CNTs-impregnated micro-
spheres may effectively overcome the drawbacks associ-
ated with microspheres containing water-soluble drug.
Metoprolol tartrate (MT) is a highly water-soluble anti-
hypertensive drug with a half-life of 3–4 h. The short bio-
logical half-life provides suitability of the drug for sustained
drug delivery. The basic nature attributes to high pKa value
(9.5) of the drug. It is prescribed alone or in combination
with other antihypertensive agents for the long-term man-
agement of angina pectoris and myocardial infarction.
Moreover, it is readily and completely absorbed from
the GIT with a bioavailability of about 50% (Martindale
2009; Chrysant 1998). Since MT requires multiple daily
dosage to maintain adequate plasma concentrations, it was
selected as a model drug for sustained release polymeric
microparticulate formulation using MWCNTs as adsorbent
(Dadashzadeh et al. 2003; Gambhire et al. 2007).
Hence, the present investigation aimed at preparing
MWCNTs-impregnated EC microspheres of a highly
water-soluble drug, MT, to achieve sustained release with
elimination of multiple daily dosing.
Materials and methods
Materials
MT was obtained as a gift sample from Sun Pharmaceu-
tical (Mumbai, India). Multi-walled carbon nanotubes
(MWCNTs) were procured from Nanoshel LLI
(Wilmington, USA). Ethyl cellulose (EC) and Tween 80
were obtained from Hi-Media (Mumbai, India). Other
chemicals were of analytical grade and used as received
without further modification. Deionized water was used
throughout the study.
Adsorption isotherm
Several reports demonstrated that CNTs had good
adsorption capacities for different materials due to their
hollow and layered nanosized structures that have a large
specific surface area (Long and Yang 2001; Li et al. 2002;
Peng et al. 2003). MT solutions were prepared by dis-
solving solid in deionized water. Batch adsorption studies
were performed in glass bottles with MT solution (100 mL)
of the prescribed concentration, ranging from 5 to
50 mg dm-3 (5 mg dm-3 interval), and adsorbent material
(MWCNTs, 0.1 g) was added to each bottle. The bottles
were capped with glass stoppers followed by sonication for
5 min and subsequently subjected to isothermal shaking
incubator (Nova, Mumbai, India) for 24 h at 30C. After
equilibration, the suspension was filtered through a
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0.22-lm filter and the filtrate was analyzed for the presence
of any unadsorbed MT content by double beam UV/visible
spectrophotometer (Shimadzu 1700, Tokyo, Japan) at
276 nm (Shinde et al. 2009). The amount of MT absorbed
by the adsorbent material (MWCNTs) was calculated
based on a mass balance equation as given below:
q ¼ ðC0  CeqÞ  V
W
where q is the amount of MT adsorbed by MWCNTs,
mg g-1; C0 and Ceq are the initial and equilibrium con-
centration of MT in the solution, mg dm-3; V is the solu-
tion volume, dm3; and W is the dry weight of adsorbent, g.
Adsorption isotherm models
Literature survey has cited various examples of drug
adsorption on the various carriers. So far, kaolin (Afolabi
2006), chitosan (Alkhamis 2001) and antacids (Aideloje
et al. 1998) have been studied for drug adsorption, and it
has been observed that depending on the surface area and
nature of the adsorbent, the extent of adsorption varies.
Langmuir, Freundlich and Sips adsorption isotherm has
been used to study the same. In the case of adsorption of
drug on MWCNTs, the same method has been employed to
study drug adsorption by MWCNTs.
The representation of the Langmuir model is given as:
qe ¼ qmKLCe
1 þ KLCe
where qe is the equilibrium MT concentration on the
adsorbent, mg g-1; Ce is the equilibrium concentration of
MT in the solution, mg l-1; qm is related to the maximum
adsorption capacity of adsorbent mg g-1; and KL is the
constant term related to energy of adsorption, dm3 mg-1.
The representation of the Freundlich model is:
qe ¼ KFC1=ne
where KF is the Freundlich constant related to the adsorbent
capacity, dm3 g-1, and 1/n measures the surface
heterogeneity.
Sips model is a combination of Langmuir and Freund-





where Keq represents the equilibrium constant of Sips
equation, dm3 mg-1; and qmax is the maximum adsorption
capacity, mg g-1. Sips isotherm model is distinguished by
the heterogeneity factor, n. Data obtained from adsorption
isotherm method were fitted to the Langmuir, Freundlich
and Sips isotherm models using a method of least square.
From the nonlinear regression coefficient (R2) and
nonlinear Chi-square test (v2) value, the best fit model was
predicted.
Preparation of drug-nanotubes adsorbate
Drug-nanotubes adsorbate (MT:MWCNTs) was prepared
by the nanoprecipitation method (Ajima et al. 2004).
Accurately weighed amount of MT was dissolved in 25 mL
of deionized water followed by addition of MWCNTs in
the required quantity. The mixture was further subjected to
sonication (Frontline FS-4, Mumbai, India) for 15 min
followed by incubation in hot air oven (Nova, Mumbai,
India) at 40C for 48 h. The residue left after evaporation
(MWCNTs:MT) was analyzed for drug content by the UV
method at 276 nm.
Drug content estimation of adsorbate
As much as 10 mg of adsorbate was added to 50 mL of
deionized water with subsequent sonication for 30 min.
The resultant solution was kept at ambient temperature for
24 h for complete extraction of MT from the adsorbate.
The dispersion was filtered through Whatman filter paper
(Sartorius Stedim, Bangalore, India) and analyzed by UV
spectroscopy.
Preparation of microspheres
MWCNTs-impregnated EC microspheres of MT were
prepared by the solvent evaporation technique (Cheu et al.
2001). Briefly, ethyl cellulose was dissolved in 25 mL of
acetone along with the prepared adsorbate. The dispersion
was further subjected to sonication for 15 min with inter-
mediate shaking. The resultant dispersion was added
dropwise to 250 mL of light liquid paraffin (containing
0.2% w/v Tween 80) with continuous stirring by magnetic
stirrer (Remi Labs, Mumbai, India). After 2 h, micro-
spheres were collected and washed with petroleum ether
with subsequent air drying at room temperature. A similar
method was utilized for preparing EC microspheres of MT
without incorporation of MWCNTs.
Experimental design
The MWCNTs:MT ratio and polymer concentration play a
crucial role in the preparation of MWCNTs-impregnated
EC microspheres of MT. Center composite design (CCD)
was employed for systemic study of joint influence of the
effect of independent variables [MWCNTs:MT (X1) and
EC:drug adsorbate (X2)] on responses such as drug
entrapment efficiency (EE) and time for 50% drug release
(t50). The selections of dependent variables were done on
the basis of the aim of the present investigation (enhanced
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encapsulation and sustained drug release). Based on pre-
liminary trials, two factors were determined as follows:
MWCNTs:MT ratio (X1): 0.25–2.75 and EC:drug adsor-
bate ratio (X2): 0.10–0.30. In this design, two factors with
five levels were probed to investigate the main effects and
interaction of the two factors on two responses (Table 1).
The design consists of nine runs (4 factorial points, 4 star
points and 1 center point) and four replicated runs (center
points) yielding 13 experiments in total. The main purpose
of the replication runs was to increase the precision and to
minimize experimental error. A third-order quadratic
model incorporating interactive and polynomial terms was
used to evaluate the response.
Yi ¼ b0 þ b1X1 þ b2X2 þ b3X21 þ b4X22 þ b5X1X2
þ b6X21X2 þ b7X1X22
where, Yi was the dependent variable, b0 was arithmetic
mean response of the 13 runs and bi was the estimated
coefficient for factor Xi. The main effects (X1 and X2)
represent the average result of changing one factor at a
time from its low to high value. The interaction terms
(X1X2) show how the response changes when two factors
are simultaneously changed. The polynomial terms (X1
2 and
X2
2) were included to investigate nonlinearity (Liu et al.
2009).
Data were further analyzed by Microsoft Excel for
regression analysis. Analysis of variance (ANOVA) was
implemented to assure that there was no significant dif-
ference between the developed full model and the reduced
model. Response surface plots were plotted to study
response variations against two independent variables
using Design Expert Version 8 software.
Characterization of microspheres
Yield of microspheres
Fresh microspheres impregnated with MWCNTs and of
drug alone were collected and weighed separately. The
measured weight of microspheres was divided by the total
amount of all nonvolatile components that were used for
the preparation (Patel et al. 2006).
%Yield ¼ Actual weight of product
Total weight of excipients and drug
 100
Entrapment efficiency (EE)
Intact microspheres (equivalent to 100 mg of drug) were
crushed and extracted with methanol. The extract was
further filtered by Whatman filter paper (Sartorius Stedim,
Bangalore, India) and diluted to 100 mL with methanol.
The drug content of filtrate was determined spectrophoto-
metrically at 276 nm (Patel et al. 2006). The amount of
drug entrapped in the microspheres was calculated as:
EE ¼ Practical drug content
Theoretical drug load expected
 100
Micromeritics
Sphericity of microspheres Photomicrographs of randomly
selected microspheres were utilized to calculate the area
(A) and perimeter (P) of the microspheres. The shape of the
microspheres was estimated by computing the shape factor
and circularity factor (Jadhav et al. 2007; Singh et al.
2007). It was calculated by the following equation.
Shape factor ¼ P0=P; where P0 ¼ 2pðA=pÞ1=2
Circularity factor ¼ P2=12:56  A
Determination of flow properties The flow behavior of
microspheres was quantified by the angle of repose and
Carr’s Index (Lee et al. 2000; Parul et al. 2008).
Instrumental analysis
Scanning electron microscopy (SEM) Surface topography
of MWCNTs, drug adsorbate and optimized batch of
microspheres were observed under a scanning electron
microscope (Model JSM 5610LV, Jeol, Japan). The sam-
ples were attached to the slab surfaces with double-sided
adhesive tapes and the scanning electron photomicrograph
was taken at 1,000–15,0009 magnification.
Powder X-ray diffraction (PXRD) Samples of MT,
MWCNTs, adsorbate, EC microspheres (without MWCNTs)
and EC microspheres impregnated with MWCNTs were
subjected to X-ray diffraction (PANalytical X’pert PRO-















-a -1 0 1 a
X1 (MWCNTs:MT) 0.25 0.62 1.50 2.38 2.75
X2 (EC:adsorbate) 0.10 0.13 0.20 0.27 0.30
a a = 1.414
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6340, India) to investigate their X-ray diffraction patterns.
The data were recorded over a range of 2–100 at a scanning
rate of 5 9 103 cps using a chart speed of 5 mm per 2.
Differential scanning calorimetry (DSC) 5–10 mg of
fresh samples as mentioned for PXRD were studied by
differential scanning calorimeter (Linseis STA PT-1600,
Germany). The samples were hermetically sealed in an
aluminum crucible before analysis. The system was purged
with nitrogen gas at a flow rate of 60 mL min-1. Heating
was done between 30 and 300C at a rate of 10C min-1.
In vitro drug release
Accurately weighed amount of microspheres (equivalent to
100 mg of drug) from each batch were subjected to dis-
solution studies using USP dissolution test apparatus type I
in 900 mL of pH 6.8 phosphate buffer maintained at
37 ± 0.5C; 5 mL aliquots were withdrawn at 10-min time
intervals for the first hour while the remaining samples
were withdrawn at 60-min time intervals for 24 h. Each
sampling was followed by the simultaneous addition of
fresh medium. The samples were filtered through Whatman
filter paper (Sartorius Stedim, Bangalore, India) before
being analyzed for the amount of drug released.
Results and discussion
Adsorption isotherm of MWCNTs for MT
Adsorption isotherm of MWCNTs for MT was studied
using Langmuir, Freundlich and Sips adsorption isotherm
models. The results of nonlinear R2 and v2 for the three
adsorption isotherms are shown in Table 2. The maximum
adsorption capacity (qm) of the MWCNTs for MT was
443.04 mg g-1 (Table 2). The RL value of the MWCNTs
(0.028) obtained from the Langmuir isotherm model for the
initial MT concentration of 50 mg dm-3 indicated favor-
able adsorption of MT onto MWCNTs. The adsorption
isotherm data for MT exhibited good fit with Langmuir
model (R2 = 0.9971) and Sips model (R2 = 0.9969) than
the Freundlich model (R2 = 0.8542). The results of the
nonlinear v2 for the three adsorption isotherms indicated
that the Langmuir isotherm model appeared to be the best
fitting model for the adsorption isotherm data of the
MWCNTs, because it displayed the lowest Chi-square,
v2 (5.43) with the highest R2 (0.9971) values. The value of
n for MT adsorption onto MWCNTs was close to unity
(n = 1.005), indicating homogeneous adsorption. Also,
there was close similarity between the maximum adsorption
capacity values obtained from Langmuir (443.04 mg g-1)
and Sips (444.67 mg g-1) isotherm models (Table 2). From
the adsorption isotherm data, it is concluded that the
MWCNTs is a good adsorbent for MT with homogeneous
adsorption to reduce batch to batch variability.
Experimental design (CCD)
Preliminary investigations of the process parameters
revealed that factors such as ratio of MWCNTs:drug (X1)
and EC:drug adsorbate (X2) exhibited significant influence
on rate of entrapment efficiency (EE) and in vitro drug
release; hence, they were utilized for further systematic
studies. Both selected dependent variables (EE and t50) for
all 13 batches showed a wide variation of 84.17–97.78%
and 5.88–15.05 h, respectively (Table 3). The data clearly
Table 2 Constant for equilibrium isotherm models with error anal-
ysis values for MT:MWCNTs adsorbate
Isotherm model Parameter value (at constant temperature, 30C)
KL qm RL R
2 v2
Langmuir 0.0572 443.04 0.028 0.9971 5.43
Isotherm model Parameter value (at constant temperature, 30C)
KF 1/n R
2 v2
Freundlich 15.7575 0.3547 0.8542 78.45
Isotherm model Parameter value (at constant temperature, 30C)
qmax Keq n R
2 v2
Sips 444.67 0.042 1.005 0.9969 14.31
KL constant term related to energy of adsorption, dm
3 mg-1; qm
maximum adsorption capacity of adsorbent, mg g-1; RL adsorption
coefficient; R2 regression coefficient; v2 Chi-square value; KF Fre-
undlich constant, dm3 g-1; qmax maximum adsorption capacity,
mg g-1; Keq equilibrium constant, dm
3 mg-1; n heterogeneity factor
Table 3 Results of experimental design batches
Batch X1 X2 EE (%) t50 (h)
1 2.38 0.13 87.42 ± 0.26 10.89 ± 0.97
2 0.62 0.27 92.94 ± 0.47 09.71 ± 0.52
3 0.25 0.20 86.08 ± 0.18 08.93 ± 0.65
4 0.62 0.13 88.04 ± 0.33 08.42 ± 0.48
5 1.50 0.10 84.17 ± 0.46 05.88 ± 0.42
6 2.75 0.20 96.01 ± 0.81 11.95 ± 0.78
7 2.38 0.27 93.84 ± 0.57 12.83 ± 0.11
8 1.50 0.30 97.78 ± 0.34 15.05 ± 0.61
9 1.50 0.20 92.04 ± 0.42 09.63 ± 0.45
10 1.50 0.20 89.97 ± 0.84 09.61 ± 0.81
11 1.50 0.20 90.52 ± 0.25 09.74 ± 0.47
12 1.50 0.20 91.85 ± 0.55 09.72 ± 0.48
13 1.50 0.20 89.47 ± 1.01 09.91 ± 0.77
X1 MWCNTs:MT, X2 EC:adsorbate, EE entrapment efficiency,
t50 time required for 50% drug release
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indicate the strong influence of X1 and X2 on selected
responses (EE and t50). The polynomial equations can be
used to draw conclusions after considering the magnitude
of coefficients and the mathematical sign carried: positive
or negative. For EE, coefficients b3, b4 and b5 were found
to be insignificant, as p values were more than 0.05 and
hence removed from the full model. Similarly, for t50,
values of b5 and b7 were insignificant and hence removed
from the full model (Table 4). Table 5 shows the results of
analysis of variance (ANOVA) performed to justify the
removal of insignificant factors. The high values of cor-
relation coefficients for EE and t50 indicate a good fit. The
critical values of F for EE and t50 were found to be 5.41
(df = 3, 5) and 5.79 (df = 2, 5), respectively, at a = 0.05.
Moreover, calculated F value [0.1742 (EE), 0.8475 (t50)]
was found to be less than critical value, which suggests no
significant difference between the full and reduced model.
The data of all the 13 batches of factorial design were used
to generate interpolated values using Design Expert
Version 8 software. High levels of both X1 and X2 were
found to be favorable for sustained release and high
entrapment efficiency. Multiple linear regression analysis
(Table 4) also revealed positive values of coefficient
b1 and b2 for both responses. This indicated that as
MWCNTs:drug ratio (X1) and EC:drug adsorbate ratio (X2)
were increased, there was a significant improvement in EE
and t50.
Influence of formulation composition factor on entrapment
efficiency (EE)
The major aim of the present investigation was to increase
the entrapment efficiency of a highly water-soluble drug,
MT. Response surface plot for EE (Fig. 1) illustrated
strong influence of two factors (MWCNTs:MT ratio and
EC:adsorbate ratio). An EE of 97.78% was observed with
MWCNTs:drug ratio 1.5 and EC:adsorbate ratio 0.30
(Batch 8). This might be attributed to the ability of
MWCNTs to prevent leaching of drug after encapsulation
inside the matrix of EC microspheres and also due to
increase in the amount of EC in the formulation that ulti-
mately increase the polymeric matrix from which MT has
to release.
Influence of formulation composition factor
on in vitro drug release (t50)
A strong influence of both independence variables
(MWCNTs: drug ratio and EC: adsorbate ratio) was
observed on in vitro drug release (t50) (Fig. 2). The highest
t50 value (15.05 ± 0.6114) was observed with Batch 8
(MWCNTs:MT ratio 1.5 and EC:adsorbate ratio 0.30). It
indicates retardation of drug release, which again endorsed
the resilience and stiffness of MWCNTs along with
increased amount of EC with respect to drug.
Table 4 Summary of regression analysis






FM 90.7700 3.5113 4.8125 0.0249 -0.0100 0.3801 -1.9825 -3.4413
RM 90.7792 3.5113 4.8125 – – – -1.9825 -3.4413
t50
FM 9.5651 1.0678 3.2425 0.3965 0.4090 0.1625 -2.4350 0.3296
RM 9.5651 1.1132 3.2425 0.3965 0.4090 – -2.4350 –
FM full model, RM reduced model, EE entrapment efficiency, t50 time required for 50% drug release
a Response is insignificant at p = 0.05
Table 5 Calculation of testing the model in portions
DF SS MS R2
EE
Regression
FM 7 174.5569 24.9367 0.9690
RM 4 173.9737 43.4934 0.9658
Error
FM 5 6.4767 1.2953
RM 8 7.2479 0.9059
t50
Regression
FM 7 59.1275 8.4467 0.9996
RM 5 58.8046 11.7609 0.9941
Error
FM 5 0.0232 0.0046
RM 7 0.3465 0.0494
DF degree of freedom, SS sum of squares, MS mean of squares,
R regression coefficient




The total yield of microspheres was determined by dividing
the measured weight with the weight of the total amount of
nonvolatile compound. The percentage yield of micro-
spheres of different batches was in the range of 92–97 wt%
(Table 6). Statistically insignificant difference was observed
for the total yield of microspheres for microspheres prepared
in the presence or absence of MWCNTs, which suggests no
major effect of MWCNTs on the yield of microspheres.
These results were far better than others previously reported
(Shabaraya and Narayanacharyulu 2003).
Entrapment efficiency
EC microspheres of highly water-soluble drug without
incorporation of MWCNTs had very less entrapment effi-
ciency, because most drugs escaped from the polymeric
matrix of microspheres (data not shown). The effect of
CNTs on the entrapment efficiency of the prepared
microspheres was very pronounced (Table 3). The entrap-
ment efficiency of the prepared microspheres varied from
84.17 to 97.78%. The entrapment efficiency was increased
significantly with increasing MWCNTs concentration,
which might be attributed to the interaction between the
drug and MWCNTs. It will diminish the overall drug
leaching from the formulation with entrapping more
amount of drug. The entrapment efficiency was found to be
highest for Batch 8. These results were far better than those
previously reported 38.9–72.1% (Shabaraya and Naray-
anacharyulu 2003).
Fig. 1 Response surface plot showing effect of entrapment efficiency
of variables [MWCNTs:MT (X1) and EC:adsorbate (X2)]
Fig. 2 Response surface plot showing effect of t50 (time required for
50% drug release) of variables [MWCNTs:MT (X1) and EC:adsorbate
(X2)]
Table 6 Characterization of experimental design batches
Batch Yield (%) Angle of repose Carr’s Index Shape factor Circularity factor
1 95.58 ± 0.41 21.34 ± 0.17 21.56 ± 0.65 1.142 ± 0.048 0.948 ± 0.004
2 96.08 ± 0.45 19.45 ± 0.21 27.64 ± 0.55 1.265 ± 0.063 0.952 ± 0.065
3 94.72 ± 0.61 18.51 ± 0.66 29.65 ± 0.41 1.366 ± 0.016 0.964 ± 0.065
4 94.14 ± 1.04 22.21 ± 1.21 19.14 ± 0.58 1.165 ± 0.016 1.065 ± 0.015
5 96.45 ± 1.48 26.14 ± 0.54 31.15 ± 1.66 1.054 ± 0.061 1.056 ± 0.098
6 93.56 ± 1.03 25.42 ± 0.45 28.15 ± 1.54 0.954 ± 0.121 1.118 ± 0.051
7 95.21 ± 1.15 26.41 ± 0.14 26.54 ± 0.19 0.969 ± 0.015 1.061 ± 0.05
8 97.22 ± 0.34 18.15 ± 0.30 15.04 ± 0.14 1.012 ± 0.004 1.001 ± 0.004
9 96.18 ± 0.47 29.16 ± 0.66 32.65 ± 0.48 1.018 ± 0.015 0.965 ± 0.061
10 95.05 ± 1.42 29.07 ± 1.31 31.45 ± 0.21 1.041 ± 0.016 0.951 ± 0.065
11 92.77 ± 0.45 29.97 ± 1.15 27.00 ± 0.67 0.984 ± 0.026 0.916 ± 0.065
12 94.13 ± 1.14 31.08 ± 0.15 29.15 ± 0.64 0.949 ± 0.014 1.042 ± 0.056
13 95.45 ± 1.11 27.45 ± 0.16 28.58 ± 0.34 0.985 ± 0.055 1.052 ± 0.067
Results are mean of triplicate observations ± SD
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Micromeritics
The formed microspheres of all batches were very good in
shape and circularity. A statistically insignificant difference
was observed for all batches of microspheres, indicating
that the shape and circularity of the microspheres (Table 6)
were not significantly influenced by MWCNTs. According
to the literature, microspheres with CI values between 5
and 15% have very good flowability. A statistically insig-
nificant difference was observed in values of Carr’s Index
for different batches of microspheres (Table 6) suggesting
that microspheres of all batches have an excellent flow-
ability irrespective of the presence of MWCNTs. More-
over, the angle of repose of most of the batches indicated a
very good flow, which suggested no significant effect of
MWCNTs on the flow properties of microspheres. Fur-
thermore, an excellent flow property of microspheres
indicates an absence of aggregation and ease of handling.
This will help in producing a uniform batch of micro-
spheres for oral delivery.
Instrumental analysis
Scanning electron microscopy (SEM) The surface mor-
phology of pure MWCNTs, drug adsorbate and MWCNTs-
impregnated EC microspheres was determined by scanning
electron microscopy (SEM) (Figs. 3, 4, 5). SEM confirmed
the fiber-like structure of pure MWCNTs, drug absorbance
on the surface of MWCNTs and spherical structure of
MWCNTs-impregnated EC microspheres. From the pho-
tograph of microspheres, it was quite clear that drug
adsorbate was trapped inside the microspheres, which
might prevent drug diffusion easily.
Powder X-Ray diffraction X-ray diffraction pattern of
MT, MWCNTs, drug adsorbate and EC microspheres with
and without MWCNTs impregnation are illustrated in
Fig. 6. The X-ray diffractogram of pure MT had sharp
peaks at diffraction angles (2h) of around 12, 19, 21 and
26, indicating a typical crystalline pattern. The spectrum
of MWCNTs showed three reflections of higher intensity at
2h of around 26, 43 and 72. The X-ray pattern of drug
adsorbate indicated characteristics peaks of both MT and
MWCNTs with slight poor reflection in the range of
5–75. All major characteristic crystalline peaks of MT
appear in the diffractogram of adsorbates, indicating the
absence of any significant conversion of crystalline state.
The lower intensity of the drug peaks in the diffractogram
of adsorbate was attributed to the physical interaction of
the drug and MWCNTs. MWCNTs-impregnated EC
microspheres exhibited complete absence of sharp peaks of
pure MT, which suggest decreased crystallinity and may be
responsible for enhanced encapsulation of drug inside the
matrix of EC.
Differential scanning calorimetry (DSC) Differential
scanning calorimetry gives reliable information on the
physicochemical state of the ingredients of microspheres
Fig. 3 SEM of MWCNTs
Fig. 4 SEM of MWCNTs:MT adsorbate showing drug (MT)
adsorption on surface of MWCNTs
Fig. 5 SEM of MWCNTs-impregnated EC microsphere
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and the possible interaction between drug and other com-
ponents of microspheres. The DSC curves are shown in
Fig. 7. MT showed an endothermic peak at 125.9C cor-
responding to its melting point and one exothermic peak at
238C, which is still under further evaluation. Drug
adsorbate also showed a similar characteristic peak with
decreased intensity showing its stability during the nano-
precipitation process. The DSC curve of adsorbate had very
little shift toward the lower side, which attributes physical
interaction MT over the surface of MWCNTs. There was a
total disappearance of endothermic peaks of the drug in
drug-loaded microspheres, which supports complete
entrapment of drug inside matrix of microspheres.
Dissolution studies
The release of any drug molecule from the reservoir-type
formulation predominantly depends upon pore size of the
reservoir, molecular weight and hydrophobicity of the drug
molecules. Devices with a larger pore size cannot control the
release of drugs effectively from the reservoir. Drug release
studies of all batches of microspheres were performed to
evaluate the potential ability of CNTs in sustaining the
release rate of drug from the microspheres. The dissolution
studies of MWCNTs-impregnated microspheres revealed
sustained drug release up to 24 h, while microspheres
without MWCNTs exhibited 90% drug release within 8 h
(Fig. 8). Batch 8 was considered as an optimized formula-
tion for sustained release microspheres of MT on the basis of
its ability to sustain drug release up to 24 h with almost 15%
drug release in the first hour. Moreover, it also exhibited the
highest value for t50 (15.05 hours) and EE (97.78%) among
all batches formulated.
This finding was in close agreement with the results
obtained by Zhang et al. (2010) for theophylline. As per
literature review, hydrophobic interaction and pore size of
the nanometer scale of MWCNTs make it difficult for the
dissolution medium to penetrate inside the matrix of
microspheres. For highly water-soluble drugs (MT), simple
entrapment inside the nanocavity was likely to be effective
for producing adequate sustained release property. From
the dissolution study, it was considered that nanometer-
scale diameter of MWCNTs and hydrophobic interaction
were the prime factors governing the release of MT. The
data obtained for in vitro release were fitted into various
release kinetic model equations (zero-order, first-order,
Hixson-Crowell, Weibull, Kosemeyer-Peppas and Higuchi
release models). The in vitro drug release of optimized
batch displayed highest regression coefficient for Higuchi’s
model indicating diffusion to be the predominant mecha-
nism of drug release (Costa and Manuel 2001; Reza et al.
2003; Gohel et al. 2000).
Fig. 6 PXRD pattern of A MT,
B MWCNTs, C MWCNTs:MT,
D EC microspheres
impregnated with MWCNTs
and E EC microspheres without
MWCNTs
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Conclusions
The present study has been a satisfactory attempt to for-
mulate a sustained release microparticulate system of a
highly water-soluble drug, MT, with an objective of min-
imizing frequency of daily dosing. It can be concluded
from experimental results that CNTs-doped EC micro-
spheres revealed high total yield, and the excellent flow
Fig. 7 DSC thermogram of A MT, B MWCNTs, C MWCNTs:MT, D EC microspheres impregnated with MWCNTs and E EC microspheres
without MWCNTs
Fig. 8 Comparison of in vitro
drug release profiles of EC
microspheres with and without
impregnation of MWCNTs
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behavior for all batches was independent of the amount of
MWCNTs incorporated. Drug entrapment efficiency of EC
microspheres prepared with drug adsorbate was very high
for all batches, which favors its use as an excellent carrier
for highly water-soluble drugs, like MT. Moreover, the
central composite design of the experiment had been suc-
cessfully employed for optimizing the formulation. The
optimized formulation (Batch 8) revealed sustained release
up to 24 h with only 15% drug release at the end of the first
hour. it was best fitted to Higuchi model out of all kinetic
models applied. Further, the retention characteristics, as
well as entrapment efficiency, are far better than all other
previous reports. However, the formulation still required an
extensive in vivo study before utilizing MWCNTs as a
carrier for the products used by human beings.
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